These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 3195997
1. Susceptibility to hydrophobic molecules and phospholipid composition in Pasteurella multocida and Actinobacillus lignieresii. Hart ME, Champlin FR. Antimicrob Agents Chemother; 1988 Sep; 32(9):1354-9. PubMed ID: 3195997 [Abstract] [Full Text] [Related]
4. Adaptive acquisition of novobiocin resistance in Pasteurella multocida strains of avian origin. Arif M, Champlin FR. Vet Res Commun; 1998 Nov; 22(7):445-55. PubMed ID: 9868759 [Abstract] [Full Text] [Related]
5. [Comparative study of species Actinobacillus lignieresii and Pasteurella haemolytica. II. Pasteurella haemolytica Newsom and Cross, 1932]. Mráz O. Zentralbl Bakteriol Orig; 1969 Nov; 209(3):336-49. PubMed ID: 5379829 [No Abstract] [Full Text] [Related]
6. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida. Morris CM, George A, Wilson WW, Champlin FR. J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392 [Abstract] [Full Text] [Related]
7. In vitro susceptibility of some porcine respiratory tract pathogens to aditoprim, trimethoprim, sulfadimethoxine, sulfamethoxazole, and combinations of these agents. Mengelers MJ, van Klingeren B, van Miert AS. Am J Vet Res; 1990 Nov; 51(11):1860-4. PubMed ID: 2240813 [Abstract] [Full Text] [Related]
8. [Antibiotic sensitivity of Pasteurella multocida and related bacteria (bacterial groups M5 and EF4). Studies of minimal inhibitory concentrations by agar dilution]. Lion C, Mory F, Conroy MC, Weber M, Burdin JC. Pathol Biol (Paris); 1986 Dec; 34(10):1061-6. PubMed ID: 3547261 [Abstract] [Full Text] [Related]
9. [Studies on growth of Pasteurella multocida on BTB agar]. Arashima Y, Iguthi K, Kawabata M, Kumasaka K, Okuyama K, Kawano K. Kansenshogaku Zasshi; 1989 Feb; 63(2):125-9. PubMed ID: 2501429 [Abstract] [Full Text] [Related]
14. Haemophilus, Actinobacillus, Pasteurella: mechanisms of resistance and antibiotic therapy. Willson PJ. Can J Vet Res; 1990 Apr; 54 Suppl():S73-7. PubMed ID: 2193709 [Abstract] [Full Text] [Related]
15. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. Dorey L, Hobson S, Lees P. Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129 [Abstract] [Full Text] [Related]
16. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media. Dorey L, Hobson S, Lees P. Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285 [Abstract] [Full Text] [Related]
17. Antibiotic susceptibilities of human isolates of Pasteurella multocida. Stevens DL, Higbee JW, Oberhofer TR, Everett ED. Antimicrob Agents Chemother; 1979 Sep; 16(3):322-4. PubMed ID: 507787 [Abstract] [Full Text] [Related]
18. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology. Dorey L, Hobson S, Lees P. Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711 [Abstract] [Full Text] [Related]
19. [Comparative study of species Actinobacillus lignieresii and Pasteurella haemolytica. I. Actinobacillus lignieresii BRUMPT, 1910; emend]. Mráz O. Zentralbl Bakteriol Orig; 1969 Jan; 209(2):212-32. PubMed ID: 5386533 [No Abstract] [Full Text] [Related]
20. Differentiation among closely related organisms of the Actinobacillus-Haemophilus-Pasteurella group by means of lysozyme and EDTA. Olsen I, Brondz I. J Clin Microbiol; 1985 Oct; 22(4):629-36. PubMed ID: 3935663 [Abstract] [Full Text] [Related] Page: [Next] [New Search]